Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Emotional Freedom Techniques in Nursing Students With Primary Dysmenorrhea

17. juni 2026 oppdatert av: Nisa Nur Demirtaş, Ataturk University

Effect of Emotional Freedom Techniques on Pain Intensity, Pain Catastrophizing, and Functional-Emotional Impact in Nursing Students With Primary Dysmenorrhea

This study will examine whether Emotional Freedom Techniques (EFT) can reduce pain intensity, pain catastrophizing, and functional-emotional impact in nursing students with primary dysmenorrhea. Eligible participants will be randomly assigned to an intervention group or a control group. The intervention group will receive EFT-based support, and the control group will continue their usual coping practices. Study outcomes will be measured before the intervention, after the intervention, and at follow-up. This study may provide evidence for a safe, non-pharmacological approach to support students with primary dysmenorrhea.

Studieoversikt

Status

Har ikke rekruttert ennå

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Antatt)

92

Fase

  • Ikke aktuelt

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Being enrolled in a nursing program,
  • Being 18 years of age or older
  • Having had a regular menstrual cycle within the last six months
  • Experiencing primary dysmenorrhea during the last three menstrual cycles
  • Reporting moderate to severe pain according to the Visual Analog Scale (VAS: 4-10)
  • Voluntary participation in the study
  • Providing written informed consent

Exclusion Criteria:

  • Having a diagnosed gynecological disease that may cause secondary dysmenorrhea (endometriosis, adenomyosis, uterine fibroids, pelvic inflammatory disease, etc.)
  • Having chronic pain syndrome
  • Receiving regular treatment or taking psychiatric medication due to a psychiatric diagnosis
  • Applying another pharmacological or non-pharmacological intervention that may affect pain perception during the research process,
  • Taking the course Obstetrics, Gynecology and Women's Health Nursing • Receiving/having received emotional freedom technique training,
  • Having previously received training in this technique or regularly using it
  • Having a cognitive or sensory problem that prevents communication or completing data collection forms
  • Not completing the application protocol
  • Incomplete completion of data collection forms
  • Wishing to withdraw from the research

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Experimental Group
Participants in the experimental group will receive a structured Emotional Freedom Techniques (EFT)-based nursing intervention. The intervention will include an individual preparation and education session 5-7 days before the expected menstruation, followed by a guided EFT session on the first day of menstrual pain. Participants will also be encouraged to perform self-application 1-2 times on the same day.
Atferdsmessig: EMOTIONAL FREEDOM TECHNIQUES (EFT)
The intervention consists of a structured Emotional Freedom Techniques (EFT)-based nursing intervention designed for nursing students with primary dysmenorrhea. It includes an individual preparation and education session conducted 5-7 days before the expected menstruation, during which pain-related thoughts, emotions, and bodily awareness are identified and individualized setup statements are developed. A guided EFT session is then conducted on the first day of menstrual pain. During this session, participants focus on dysmenorrhea-related distress while repeating the individualized setup statements and following the structured EFT sequence under researcher guidance. Pain intensity and subjective distress are assessed before and after the guided session. Participants are also advised to repeat the EFT self-application 1-2 times on the same day.
Ingen inngripen: Control Grup
Participants in the control group will not receive the EFT-based nursing intervention during the study period and will continue their usual coping methods for menstrual pain without any additional structured support.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Pain Intensity
Tidsramme: Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
Pain intensity will be assessed using the Visual Analog Scale (VAS). Participants will rate the most severe menstrual pain experienced during the relevant menstrual cycle on a 0-10 scale, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
Pain Catastrophizing
Tidsramme: Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
Pain catastrophizing will be assessed using the Pain Catastrophizing Scale (PCS). Total scores range from 0 to 52. Higher scores indicate greater pain catastrophizing and therefore a worse outcome.
Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
Functional-Emotional Impact
Tidsramme: Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
Functional-emotional impact will be assessed using the Functional and Emotional Dysmenorrhea Scale (FEDS). Total scores range from 14 to 70. Higher scores indicate greater functional and emotional impact of dysmenorrhea and therefore a worse outcome.
Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Ataturk University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

19. juni 2026

Primær fullføring (Antatt)

19. oktober 2026

Studiet fullført (Antatt)

19. desember 2026

Datoer for studieregistrering

Først innsendt

12. juni 2026

Først innsendt som oppfylte QC-kriteriene

17. juni 2026

Først lagt ut (Faktiske)

22. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

22. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

17. juni 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Andre studie-ID-numre

  • B.30.2.ATA.0.01.00/252

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere